Together, Thomas L. Mindt and his cooperation-partners Wolfgang Kandioller (University of Vienna) and Berthold Nock (Demokritos, Athens) received a grant by the Austrian Science Fund for the new project on “Metabolically Stabilized Peptidomimetics for Improved Tumour Targeting”. Go and read more about the project..
Prof. Dr. Thomas L. Mindt, Head of Imaging Biomarkers, was invited to deliver the plenary lecture at the 4th national congress of the Korean Society of Radiopharmaceuticals and Molecular Probes (KSRAMP) 2017 in Daejeon, Korea.His presentation was entitled “Of Established and Emerging Radiometals” and included an overview on the use of new radionuclides (e.g., Zr-89, […]
With a quite big team of already 14 employees, the LBI Applied Diagnostics decided to be ready to celebrate its inauguration on the 2nd of May 2017. For this occasion, nothing less than the stunning location, Wolke 21 was chosen which is situated in Vienna’s 22nd district. The impressive location provided a delightful view from […]
